Search clinical trials for: Antibodies, Anti-Idiotypic

Total 88430 results

Zhejiang University

Recruiting

Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients (CISLD-8)

Hepatocellular Carcinoma

China
Sohag University

Completed

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

Urothelial Carcinoma

Egypt
Xiujuan Zhao

Unknown

The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset

Optic Neuritis

China
Daiichi Sankyo, Inc.

Completed

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)

Lymphoma | Malignancies

United States
Bristol-Myers Squibb

Completed

Multiple Ascending Dose (MDX1105-01) (Anti-PDL1)

Cancer, Multiple Indications

United States
Shandong New Time Pharmaceutical Co., LTD
Sun Yat-sen University

Not yet recruiting

Phase I Study of LNF1901 in Advanced Malignant Tumors

Advanced Malignant Tumors
Kyungpook National University Hospital

Recruiting

Neutralizing Antibody Level After COVID-19 Vaccination

Covid19

Korea, Republic of
Henry Ford Health System

Recruiting

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Covid19

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
Eisai Inc.

Completed

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Metastatic Melanoma

United States, Australia, United Kingdom, Germany
Light Chain Bioscience - Novimmune SA

Completed

First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers (NI-0101-01)

Healthy Volunteers

Netherlands
National Center for Research Resources (NCRR)
Stanford University

Completed

A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis

Multiple Sclerosis
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Beijing Children's Hospital; Tianjin Medical University... and other collaborators

Recruiting

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP)

China
M.D. Anderson Cancer Center

Active, not recruiting

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Locally Advanced Angiosarcoma | Metastatic Angiosarcoma | Recurrent Angiosarcoma

United States
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL95 in Advanced Malignancies.

Advanced Malignancies

China
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Medical University of Silesia

Unknown

Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration (EpiSARS2)

Severe Acute Respiratory Syndrome | RNA Virus Infections | Respiratory Tract Infections | Covid19 | Corona Virus Infection | Respiratory Tract Disease | Virus Disease

Poland
Guangzhou University of Traditional Chinese Medicine

Unknown

PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma

Lymphoepithelioma-Like Carcinoma

China
Sherief Abd-Elsalam

Unknown

Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?

Hepatitis B

Egypt
Academisch Medisch Centrum - Universiteit van Amsterdam...
Agenus Inc.; Dutch Cancer Society

Not yet recruiting

ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study (ITHACA)

Cervical Cancer

Netherlands
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

IBI310 in Combination With Sintilimab in Patients With DNA Mismatch Repair Deficient (dMMR)/Microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal Cancer

Colorectal Cancer

China
Northwestern University
National Cancer Institute (NCI)

Recruiting

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Locally Advanced Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Oncocytic Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditions

United States
National Yang Ming University

Recruiting

Effects of SugarCut® Unripe Guava Fruit Extract on Blood Glucose Regulation

PreDiabetes

Taiwan
Beijing Boren Hospital

Recruiting

Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19

COVID-19 | Hematological Disorders

China
Istituto Clinico Humanitas

Unknown

Detection of Anti-COVID-19 Antibody Levels in an Hospital Population

COVID-19

Italy
Sun Yat-sen University

Unknown

A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Renal Cell Carcinoma | Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Non-small-cell Lung Cancer | Bladder Cancer

China
Centre Hospitalier Universitaire de Pointe-a-Pitre

Unknown

Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (CHIKIVIG-01)

Chikungunya Virus Infection

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Biomedicines and Bacterial Translocation in Spondyloarthritis (TEARE-BIO)

Axial Spondyloarthritis

France
Baxalta now part of Shire

Completed

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Malignant Solid Tumors | Metastatic Adenocarcinoma of the Colon or Rectum

Germany, United States
Novartis Pharmaceuticals

Completed

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients (OPTIMA)

Chronic Spontaneous Urticaria

Argentina, Dominican Republic, Canada, Brazil, Guatemala, Chile, Mexico, Panama
TiumBio Co., Ltd.

Recruiting

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Korea, Republic of, United States
LaNova Australia Pty Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

Australia
Sun Yat-sen University

Recruiting

COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer (CORRECT)

Biliary Tract Cancer | Radiotherapy | Immunotherapy

China
Providence Health & Services
MedImmune LLC

Completed

Anti-OX40 Antibody in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Janssen Research & Development, LLC

Completed

A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes

Type 2 Diabetes

Switzerland
Sun Yat-sen University

Unknown

A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
The University of Hong Kong

Completed

Optimizing HBV Management During Anti-CD20 Antibodies

Hepatitis B | Liver Dysfunction | Immune Suppression

Hong Kong
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institute of Diabetes and Digestive and...

Completed

Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes (TN14)

Type 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 Diabetes

United States, Canada
Rockefeller University
University Hospital of Cologne

Completed

3BNC117 and 10-1074 in HIV-infected Individuals

Human Immunodeficiency Virus (HIV)

United States, Germany
Second Affiliated Hospital, School of Medicine,...

Recruiting

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC (RAIC)

Rectal Neoplasms

China
Wake Forest University Health Sciences

Withdrawn

Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma

Amputation | Urologic Injuries | Genital Diseases, Male
Shanghai Henlius Biotech

Not yet recruiting

A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects

IPF
University of Colorado, Denver
University of Rochester

Enrolling by invitation

Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

Surgical Site Infection | Staphylococcus Aureus Infection | Orthopedic Procedures | Spine

United States
University of Pennsylvania
Inovio Pharmaceuticals

Completed

A Study of INO-A002 in Healthy Dengue Virus-naive Adults

Healthy Volunteers

United States
Institute of Health Information and Statistics...
Institute for Clinical and Experimental Medicine; University Hospital Olomouc; The Institute of Molecular and Translational Medicine, Czech Republic and other collaborators

Completed

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

COVID-19 | SARS-CoV-2 Infection

Czechia
Janssen Research & Development, LLC

Completed

A Study of Bermekimab in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Beijing Mabworks Biotech Co., Ltd.

Completed

A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas

CD20-positive B Cell Non-Hodgkin Lymphoma

China
John Mascarenhas

Terminated

Anti-TGF-beta Therapy in Patients With Myelofibrosis

Primary Myelofibrosis | Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-essential Thrombocythemia Related Myelofibrosis

United States

Search clinical trials for: Antibodies, Anti-Idiotypic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations